$8.41 -0.03 (-0.36%)
11/25/2009 4:00 PM

NeurogesX, Inc. (NGSX)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Featured Broker Partners